{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/magnesium",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984750",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984750_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"alendronate\" outputclass=\"int-drug\">alendronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronate</xref></ph> should be taken at least 30 minutes before magnesium</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   decreases   the absorption of   oral   alendronate .  Manufacturer advises  alendronate  should be taken at least 30 minutes before magnesium .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alendronate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984751",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984751_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"amlodipine\" outputclass=\"int-drug\">amlodipine</ph> <ph outputclass=\"int-substanceQualifier\">in pregnant women</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   amlodipine   in pregnant women .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amlodipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984752",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984752_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"atracurium\" outputclass=\"int-drug\">atracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   increases   the effects of   atracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atracurium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984753",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984753_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Baloxavir marboxil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984754",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984754_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-substanceQualifier\">trisilicate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"chloroquine\" outputclass=\"int-drug\">chloroquine</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 4 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   trisilicate   decreases   the absorption of   oral   chloroquine .  Manufacturer advises separate administration by at least 4 hours .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Chloroquine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984755",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984755_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   increases   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cisatracurium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984756",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984756_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"clodronate\" outputclass=\"int-drug\">clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid magnesium for 2 hours before or 1 hour after <ph otherprops=\"clodronate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   decreases   the absorption of   oral   clodronate .  Manufacturer advises avoid magnesium for 2 hours before or 1 hour after  clodronate .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clodronate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984757",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984757_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"felodipine\" outputclass=\"int-drug\">felodipine</ph> <ph outputclass=\"int-substanceQualifier\">in pregnant women</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   felodipine   in pregnant women .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Felodipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984758",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984758_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-substanceQualifier\">trisilicate</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"hydroxychloroquine\" outputclass=\"int-drug\">hydroxychloroquine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   trisilicate   is predicted to   decrease   the absorption of   oral   hydroxychloroquine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hydroxychloroquine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984759",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984759_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid for at least 6 hours before or 1 hour after <ph otherprops=\"ibandronate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   is predicted to   decrease   the absorption of   oral   ibandronate .  Manufacturer advises avoid for at least 6 hours before or 1 hour after  ibandronate .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ibandronate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984760",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984760_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"lacidipine\" outputclass=\"int-drug\">lacidipine</ph> <ph outputclass=\"int-substanceQualifier\">in pregnant women</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   lacidipine   in pregnant women .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lacidipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984761",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984761_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"lercanidipine\" outputclass=\"int-drug\">lercanidipine</ph> <ph outputclass=\"int-substanceQualifier\">in pregnant women</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   lercanidipine   in pregnant women .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lercanidipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984762",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984762_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"mivacurium\" outputclass=\"int-drug\">mivacurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   increases   the effects of   mivacurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mivacurium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984763",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984763_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"nicardipine\" outputclass=\"int-drug\">nicardipine</ph> <ph outputclass=\"int-substanceQualifier\">in pregnant women</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   nicardipine   in pregnant women .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nicardipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984764",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984764_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"nifedipine\" outputclass=\"int-drug\">nifedipine</ph> <ph outputclass=\"int-substanceQualifier\">in pregnant women</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   nifedipine   in pregnant women .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nifedipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984765",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984765_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"nimodipine\" outputclass=\"int-drug\">nimodipine</ph> <ph outputclass=\"int-substanceQualifier\">in pregnant women</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor blood pressure</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   nimodipine   in pregnant women .  Manufacturer advises monitor blood pressure .    \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nimodipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984766",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984766_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-substanceQualifier\">trisilicate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"nitrofurantoin\" outputclass=\"int-drug\">nitrofurantoin</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   trisilicate   decreases   the absorption of   oral   nitrofurantoin .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nitrofurantoin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984767",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984767_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"pancuronium\" outputclass=\"int-drug\">pancuronium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   increases   the effects of   pancuronium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pancuronium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984768",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984768_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"risedronate\" outputclass=\"int-drug\">risedronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   decreases   the absorption of   oral   risedronate .  Manufacturer advises separate administration by at least 2 hours .    \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Risedronate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984769",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984769_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"rocuronium\" outputclass=\"int-drug\">rocuronium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   increases   the effects of   rocuronium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rocuronium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984770",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984770_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">Magnesium</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"roxadustat\" outputclass=\"int-drug\">roxadustat</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"roxadustat\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/roxadustat.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP223244\">roxadustat</xref></ph> should be taken at least 1 hour after magnesium</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Magnesium   might   decrease   the exposure to   roxadustat .  Manufacturer advises  roxadustat  should be taken at least 1 hour after magnesium .    \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Roxadustat</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984771",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984771_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   is predicted to   increase   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Suxamethonium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984772",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984772_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"vecuronium\" outputclass=\"int-drug\">vecuronium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   increases   the effects of   vecuronium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vecuronium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984773",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/magnesium#bnf_i1643857984773_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-heading-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypotension when given with</ph> <ph otherprops=\"verapamil\" outputclass=\"int-drug\">verapamil</ph> <ph outputclass=\"int-substanceQualifier\">in pregnant women</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   potentially   increases   the risk of hypotension when given with   verapamil   in pregnant women .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Verapamil</title>"
					}
				}
			],
			"hasSearchLabel": " Magnesium  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/magnesium.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Magnesium </title>"
			},
			"rdfs:label": "magnesium"
		}
	]
}